V. Romagnoli

830 total citations
17 papers, 566 citations indexed

About

V. Romagnoli is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, V. Romagnoli has authored 17 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in V. Romagnoli's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). V. Romagnoli is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). V. Romagnoli collaborates with scholars based in Italy, Canada and China. V. Romagnoli's co-authors include Maurizia Rossana Brunetto, P. Colombatto, Ferruccio Bonino, Filippo Oliveri, B. Coco, P. Ciccorossi, B. Cherubini, D. Cavallone, F. Moriconi and Giovanna Moscato and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Hepatology.

In The Last Decade

V. Romagnoli

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Romagnoli Italy	8	523	483	35	34	30	17	566
Louis Jansen Netherlands	12	369 0.7×	312 0.6×	43 1.2×	52 1.5×	33 1.1×	22	432
B. Cherubini Italy	6	601 1.1×	554 1.1×	36 1.0×	31 0.9×	29 1.0×	10	624
C.-M. Lee Taiwan	10	364 0.7×	365 0.8×	16 0.5×	12 0.4×	25 0.8×	13	407
J.-H. Wang Taiwan	10	364 0.7×	366 0.8×	16 0.5×	8 0.2×	25 0.8×	13	403
Stephan Chiu United States	8	131 0.3×	167 0.3×	56 1.6×	96 2.8×	82 2.7×	13	347
David Yardeni Israel	9	207 0.4×	186 0.4×	7 0.2×	25 0.7×	21 0.7×	36	278
Zunaira Awan Pakistan	10	261 0.5×	277 0.6×	6 0.2×	39 1.1×	49 1.6×	15	343
Mark Sulkowski United States	4	268 0.5×	257 0.5×	5 0.1×	20 0.6×	20 0.7×	6	310
Zehui Yan China	11	253 0.5×	237 0.5×	11 0.3×	26 0.8×	22 0.7×	18	354
Taotao Yan China	11	247 0.5×	190 0.4×	12 0.3×	36 1.1×	42 1.4×	31	298

Countries citing papers authored by V. Romagnoli

Since Specialization

Citations

This map shows the geographic impact of V. Romagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Romagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Romagnoli more than expected).

Fields of papers citing papers by V. Romagnoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Romagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Romagnoli. The network helps show where V. Romagnoli may publish in the future.

Co-authorship network of co-authors of V. Romagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of V. Romagnoli. A scholar is included among the top collaborators of V. Romagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Romagnoli. V. Romagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ricco, G., D. Cavallone, P. Colombatto, et al.. (2023). HDV RNA levels <1000 IU/ml and total anti-HDV titers <1:1000 identify chronic hepatitis D subjects without active liver disease. Journal of Hepatology. 78. S1091–S1091. 1 indexed citations

Ricco, G., B. Coco, P. Colombatto, et al.. (2022). Highly dynamic changes of regional HBV epidemiology over two decades. Digestive and Liver Disease. 55(4). 519–526. 10 indexed citations

Colombatto, P., G. Ricco, D. Cavallone, et al.. (2022). Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy. Journal of Clinical Medicine. 11(5). 1406–1406. 2 indexed citations

Salvati, A, Francesco Faita, D. Cavallone, et al.. (2021). Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?. Hepatoma Research. 2021. 2 indexed citations

Colombatto, P., Coşkun Özer Demirtaş, G. Ricco, et al.. (2021). Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers. 13(9). 2064–2064. 3 indexed citations

Cavallone, D., G. Ricco, Filippo Oliveri, et al.. (2020). Do the circulating Pre‐S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?. Alimentary Pharmacology & Therapeutics. 51(12). 1406–1416. 5 indexed citations

Colantonio, Sara, et al.. (2019). An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study. Sensors. 19(17). 3656–3656. 12 indexed citations

Oliveri, Filippo, D. Cavallone, P. Colombatto, et al.. (2017). Long‐term outcome of inactive and active, low viraemic HBeAg‐negative‐hepatitis B virus infection: Benign course towards HBsAg clearance. Liver International. 37(11). 1622–1631. 49 indexed citations

Ricco, G., D. Cavallone, Patrizia Pontisso, et al.. (2017). In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapy. Journal of Hepatology. 66(1). S212–S212. 1 indexed citations

10.

Brunetto, Maurizia Rossana, D. Cavallone, Filippo Oliveri, et al.. (2014). A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection. PLoS ONE. 9(10). e110782–e110782. 38 indexed citations

11.

Ricco, G., F. Moriconi, P. Colombatto, et al.. (2014). Early prediction of sustained virologic response by HCV Core Ag kinetics in chronic hepatitis C patients treated with Peginterferon plus Ribavirin. Digestive and Liver Disease. 46. e46–e46. 1 indexed citations

12.

Colombatto, P., F. Moriconi, Filippo Oliveri, et al.. (2013). T-06 Early HCV-Core-Ag kinetics predict sustained virologic response in chronic hepatitis C patients treated with standard of care. Digestive and Liver Disease. 45. S14–S15. 1 indexed citations

13.

Antonelli, Dario, Paolo Chiabert, & V. Romagnoli. (2013). Information System and Systems Thinking: a Compulsory Marriage?. IFAC Proceedings Volumes. 46(9). 1780–1785. 1 indexed citations

14.

Colombatto, P., Maurizia Rossana Brunetto, A.M. Maina, et al.. (2013). HCV E1E2‐MF59 vaccine in chronic hepatitis C patients treated with PEG‐IFNα2a and Ribavirin: a randomized controlled trial. Journal of Viral Hepatitis. 21(7). 458–465. 19 indexed citations

15.

Brunetto, Maurizia Rossana, Filippo Oliveri, P. Colombatto, et al.. (2010). Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers. Gastroenterology. 139(2). 483–490. 305 indexed citations

16.

Colombatto, P., P. Ciccorossi, A.M. Maina, et al.. (2008). Early and Accurate Prediction of Peg-IFNs/Ribavirin Therapy Outcome in the Individual Patient With Chronic Hepatitis C by Modeling the Dynamics of the Infected Cells. Clinical Pharmacology & Therapeutics. 84(2). 212–215. 10 indexed citations

17.

Oliveri, Filippo, B. Coco, P. Ciccorossi, et al.. (2008). Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminases. World Journal of Gastroenterology. 14(40). 6154–6154. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact